1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2020;42(5):373–498. DOI: 10.1093/eurheartj/ehaa612
2. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW,Carson AP et al. Heart Disease and Stroke Statistics – 2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139–596. DOI: 10.1161/CIR.0000000000000757
3. Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, allcause mortality and heart failure: A systematic review and meta-analysis. European Journal of Preventive Cardiology. 2017;24(14):1555–66. DOI: 10.1177/2047487317715769
4. Freedman B, Potpara TS, Lip GYH. Stroke prevention in atrial fibrillation. The Lancet. 2016;388(10046):806–17. DOI: 10.1016/S0140-6736(16)31257-0
5. Son Y-J, Baek K-H, Lee SJ, Seo EJ. Health-Related Quality of Life and Associated Factors in Patients with Atrial Fibrillation: An Integrative Literature Review. International Journal of Environmental Research and Public Health. 2019;16(17):3042. DOI: 10.3390/ijerph16173042
6. Ladwig K-H, Goette A, Atasoy S, Johar H. Psychological aspects of atrial fibrillation: A systematic narrative review: Impact on incidence, cognition, prognosis, and symptom perception. Current Cardiology Reports. 2020;22(11):137. DOI: 10.1007/s11886-020-01396-w
7. Antyufeva V.F., Menshchikova I.A., Bashkov V.S. Paroxysmal form of atrial fibrillation. Interaction of electrophysiological and psychological aspects. Clinical medicine. 1990;68(8):59–60.
8. Thrall G, Lane D, Carroll D, Lip GYH. Quality of Life in Patients with Atrial Fibrillation: A Systematic Review. The American Journal of Medicine. 2006;119(5):448.e1-448.e19. DOI: 10.1016/j.amjmed. 2005.10.057
9. Patel D, Mc Conkey ND, Sohaney R, Mc Neil A, Jedrzejczyk A, Armaganijan L. A Systematic Review of Depression and Anxiety in Patients with Atrial Fibrillation: The Mind-Heart Link. Cardiovascular Psychiatry and Neurology. 2013;2013:159850. DOI: 10.1155/2013/159850
10. Frasure-Smith N, Lespérance F, Habra M, Talajic M, Khairy P,Dorian P et al. Elevated Depression Symptoms Predict Long-Term Cardiovascular Mortality in Patients With Atrial Fibrillation and Heart Failure. Circulation. 2009;120(2):134–40. DOI: 10.1161/CIRCULATIONAHA. 109.851675
11. Sang C-H, Chen K, Pang X-F, Dong J-Z, Du X, Ma H et al. Depression, Anxiety, and Quality of Life After Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation. Clinical Cardiology. 2013;36(1):40–5. DOI: 10.1002/clc.22039
12. Wokhlu A, Monahan KH, Hodge DO, Asirvatham SJ, Friedman PA, Munger TM et al. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. Journal of the American College of Cardiology. 2010;55(21):2308–16. DOI: 10.1016/j.jacc.2010.01.040
13. Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS et al. Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2011;22(8):839–45. DOI: 10.1111/j.1540-8167.2011.02035.x
14. Efremidis M, Letsas KP, Lioni L, Giannopoulos G, Korantzopoulos P, Vlachos K et al. Association of Quality of Life, Anxiety, and Depression with Left Atrial Ablation Outcomes. Pacing and Clinical Electrophysiology. 2014;37(6):703–11. DOI: 10.1111/pace.12420
15. Andryushchenko A.V., Drobizhev M.Yu., Dobrovolsky A.V. Comparative evaluation of the CES-D, BDI and HADS(D) scale in the diagnosis of depression in General medical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2003;103(5):11–8.
16. Pogosova N.V., Dovzhenko T.V., Babin A.G., Kursakov A.A., Vygodin V.A. Russian version of PHQ-2 and 9 Questionnaires: sensitivity and specificity in detection of depression in outpatient general medical practice. Cardiovascular Therapy and Prevention. 2014;13(3):18–24.. DOI: 10.15829/1728-8800-2014-3-18-24
17. Batarshev A.V. Basic psychological properties and self-determination of personality: a Practical guide to psychological diagnosis. –SPb: Speech;2005. –208 p.. ISBN 5-9268-0364-0
18. Chauvet-Gelinier J-C, Bonin B. Stress, anxiety and depression in heart disease patients: A major challenge for cardiac rehabilitation. Annals of Physical and Rehabilitation Medicine. 2017;60(1):6–12. DOI: 10.1016/j.rehab.2016.09.002
19. Compare A, Mommersteeg PMC, Faletra F, Grossi E, Pasotti E, Moccetti T et al. Personality traits, cardiac risk factors, and their association with presence and severity of coronary artery plaque in people with no history of cardiovascular disease: Journal of Cardiovascular Medicine. 2014;15(5):423–30. DOI: 10.2459/JCM.0b013e328365cd8c
20. Blumenthal JA, Sherwood A, Smith PJ, Watkins L, Mabe S, Kraus WE et al. Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial. Circulation. 2016;133(14):1341–50. DOI: 10.1161/CIRCULATIONAHA. 115.018926
21. Albus C, Herrmann-Lingen C, Jensen K, Hackbusch M, Münch N,Kuncewicz C et al. Additional effects of psychological interventions on subjective and objective outcomes compared with exercise-based cardiac rehabilitation alone in patients with cardiovascular disease: A systematic review and meta-analysis. European Journal of Preventive Cardiology. 2019;26(10):1035–49. DOI: 10.1177/2047487319832393
22. Richards SH, Anderson L, Jenkinson CE, Whalley B, Rees K, Davies P et al. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. European Journal of Preventive Cardiology. 2018;25(3):247–59. DOI: 10.1177/2047487317739978
23. Risom SS, Zwisler A-D, Thygesen LC, Svendsen JH, Berg SK. High Readmission Rates and Mental Distress 1 yr After Ablation for Atrial Fibrillation or Atrial Flutter: A NATIONWIDE SURVEY. Journal of Cardiopulmonary Rehabilitation and Prevention. 2019;39(1):33–8. DOI: 10.1097/HCR.0000000000000395
24. Risom SS, Zwisler A-DO, Rasmussen TB, Sibilitz KL, Svendsen JH, Gluud C et al. The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: the randomised CopenHeartRFA trial protocol. BMJ Open. 2013;3(2):e002377. DOI: 10.1136/bmjopen-2012-002377
25. Risom SS, Lind J, Dickson VV, Berg SK. Exploring the Mechanism of Effectiveness of a Psychoeducational Intervention in a Rehabilitation Program (CopenHeartRFA) for Patients Treated With Ablation for Atrial Fibrillation: A Mixed Methods Study. Journal of Cardiovascular Nursing. 2019;34(4):336–43. DOI: 10.1097/JCN.0000000000000584
26. Risom SS, Lind J, McCabe P, Berg S. Patient perspectives of participating in the cardiac CopenHeartRFA rehabilitation program for patients treated with ablation for atrial fibrillation. Journal of Multidisciplinary Healthcare. 2018;11:167–74. DOI: 10.2147/JMDH.S152823
27. Bubnova M.G., Aronov D.M. Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation. Rational Pharmacotherapy in Cardiology. 2020;16(5):804–14.. DOI: 10.20996/1819-6446-2020-10-21
28. Bubnova M.G., Aronov D.M., Makhinova M.M. Radiofrequency ablation and antiarrhythmic therapy in the treatment of patients with paroxysmal and persistent atrial fibrillation: clinical effects. Cardiosomatics. 2015;6(3):38–47.